AEON Biopharma, Inc.
AEON Biopharma, Inc.（AEON）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
aeon · 股价预测 · 2 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 2 位华尔街分析师
Buy
2 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.74
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.71 | ↓ 3.50% |
1-day model range: $0.69–$0.73. Peak: $0.73 (-3.50%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -29.7% |
| 2028 | — | -40.1% |
| 2029 | — | -44.6% |
| 2030 | — | -46.6% |
| 2031 | — | -47.6% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · AEON · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-10-08 | Aegis Capital | Maintains | Buy→Buy |
| 2024-10-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-07-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-04-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on AEON Biopharma, Inc. (AEON) stock. Of the recent 8 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover AEON.
分析师推荐趋势
AEON analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$4.4B
↑ 26787.3% YoY
Revenue Next Year
$1M
↓ 100.0% YoY
EPS This Year
$51.84
EPS Next Year
$-0.61
↓ 101.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast AEON EPS of $51.84 for the current fiscal year, based on estimates from 1 analysts. The AEON revenue forecast is $4.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AEON 股价预测由两类独立数据源支撑：来自 2 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AEON 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
AEON 的短期预测（明日）为 $0.71（-3.50%）。 AEON 对 2030 年的预测区间为 $0–$0。
AEON Biopharma, Inc. 在 AMEX 上市，代码 AEON。AEON 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
AEON 预测 · 8 个问题根据 2 位华尔街分析师，AEON 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.74，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.